ClinicalTrials.Veeva

Menu

Evaluation of ARi with OpSens SavvyWire

O

OpSens

Status

Terminated

Conditions

Aortic Valve Insufficiency

Treatments

Device: Transcatheter Aortic Valve Replacement (TAVR)
Device: Balloon Aortic Valvuloplasty (BAV)

Study type

Observational

Funder types

Industry

Identifiers

NCT06295068
PRT-1400-11

Details and patient eligibility

About

The goal of this observational study is to establish the degree of agreement to Aortic Regurgitation (AR) severity during aortic valve intervention between the Aortic Regurgitation Index (ARi) measured by the Opsens SavvyWire, Echography and Aortography in subjects with severe aortic stenosis (AS) undergoing echo guided valve intervention. The main question it aims to answer is how the ARi measured with the Opsens SavvyWire compared with regurgitation evaluation derived by Echography and Aortography.

Enrollment

13 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing TAVR suitable for intraoperative acquisition of TEE/TTE
  • Age > 18 years
  • Able and willing to give informed consent.

Exclusion criteria

  • Hemodynamic instability making use of additional hemodynamic measurement inappropriate or 24-hour survival unlikely
  • Subject is considered part of a vulnerable population.

Trial contacts and locations

1

Loading...

Central trial contact

Samuel Magnan, B.Sc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems